+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Current situation and prospect of minimal residual disease in acute myeloid leukemia



Current situation and prospect of minimal residual disease in acute myeloid leukemia



Zhonghua Xue Ye Xue Za Zhi 40(1): 83-86




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 066446355

Download citation: RISBibTeXText

PMID: 30704237


Related references

Minimal residual disease in acute myeloid leukemia--current status and future perspectives. Current Hematologic Malignancy Reports 10(2): 132-144, 2016

Monitoring of minimal residual disease in NPM1-mutated acute myeloid leukemia: a study from the German-Austrian acute myeloid leukemia study group. Journal of Clinical Oncology 29(19): 2709-2716, 2011

Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia 13(12): 1901-1928, 1999

Comparison of minimal residual disease (MRD) monitoring by WT1 quantification between childhood acute myeloid leukemia and acute lymphoblastic leukemia. European Review for Medical and Pharmacological Sciences 19(14): 2679-2688, 2016

Increase in myeloid-derived suppressor cells (MDSCs) associated with minimal residual disease (MRD) detection in adult acute myeloid leukemia. International Journal of Hematology 102(5): 579-586, 2016

Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia. Neoplasma 54(6): 471-477, 2007

Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: report of the BIOMED-1 CONCERTED ACTION: investigation of minimal residual disease in acute leukemia. Leukemia 13(1): 110-118, 1999

Minimal Residual Disease in Acute Myeloid Leukemia. Advances in Experimental Medicine and Biology 1100: 111-125, 2018

Minimal Residual Disease in Acute Myeloid Leukemia. Current Treatment Options in Oncology 18(1): 1, 2017

IDH1/2 but not DNMT3A mutations are suitable targets for minimal residual disease monitoring in acute myeloid leukemia patients: a study by the Acute Leukemia French Association. Oncotarget 6(39): 42345-42353, 2016

Leukemia derived dendritic cells in acute myeloid leukemia A new immunotherapeutic modality in minimal residual disease?. Leukemia 15(3): 494, 2001

Minimal residual disease in acute myeloid leukemia: coming of age. Hematology. American Society of Hematology. Education Program 2012: 35-42, 2013

Detection of minimal residual disease in acute myeloid leukemia. Scripta Medica 73(4): 223-228, 2000

Molecular Minimal Residual Disease in Acute Myeloid Leukemia. New England Journal of Medicine 378(13): 1189-1199, 2018

Introducing minimal residual disease in acute myeloid leukemia. Current Opinion in Hematology 22(2): 139-145, 2015